Clinical Trial Update: Evaluation of Myocardial Reperfusion After Primary PCI in Patients With High Platelet Reactivity Treated by Cangrelor or Not [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update assesses myocardial reperfusion after primary PCI in patients with ST-segment elevation myocardial infarction and high platel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-segment Elevation Myocardial Infarction

Drugs mentioned

• Kengreal (cangrelor)

Snippet

Sponsor: University Hospital, Caen | Conditions: ST-elevation Myocardial Infarction | Phase 4 | Status: COMPLETED